Triethylamine → HCID 178527247、化合物
反応式
N[C:2]1[CH:11]=[C:10]2[C:5]([C:6]([NH:12][C:13]3[CH:18]=[CH:17][CH:16]=[C:15]([Br:19])[CH:14]=3)=[N:7][CH:8]=[N:9]2)=[CH:4][CH:3]=1.[CH2:20]([N:22](CC)CC)[CH3:21].N1C=CC=CC=1.CNC.ClCC[S:39](Cl)(=[O:41])=[O:40]>O1CCCC1.C([O-])(O)=O.[Na+]>[Br:19][C:15]1[CH:14]=[C:13]([NH:12][C:6]2[C:5]3[C:10](=[CH:11][C:2]([CH:21]=[CH:20][NH:22][SH:39](=[O:41])=[O:40])=[CH:3][CH:4]=3)[N:9]=[CH:8][N:7]=2)[CH:18]=[CH:17][CH:16]=1参加物
実験手順
A solution of 7-amino-4-[(3-bromophenyl)-amino]quinazoline (J Med Chem, 1995;38:3482) (500 mg, 1.59 mmol), triethylamine (Et3N) (0.60 mL) and dimethylamine pyridine (DMAP) (catalytic) in tetrahydrofuran (THF) (30 mL) was reacted with chloroethanesulfonyl chloride (1.6 mol eq., 2.54 mmol, 265 μL) at 25° C. for 1 hour, stirred under N2. The reaction mixture was diluted with saturated NaHCO3 and extracted with EtOAc. The combined organic extracts were washed with brine, dried over anhydrous Na2SO4, concentrated under reduced pressure, and chromatographed on silica gel eluting with MeOH/CH2Cl2/EtOAc (3:47:50). Crystallization from CH2Cl2/hexane, gave N-[4-[(3-bromophenyl)amino]-quinazolin-7-yl]vinylsulfonamide (80 mg, 12%) as a cream powder, mp 218° C. decomposes (dec).
後処理
- extractionextracted with EtOAc
- washThe combined organic extracts were washed with brine
- dry with materialdried over anhydrous Na2SO4
- concentrationconcentrated under reduced pressure
- customchromatographed on silica gel eluting with MeOH/CH2Cl2/EtOAc (3:47:50)
- customCrystallization from CH2Cl2/hexane
出典と根拠
- ORDレコード
- ord-94d5aaf94deb4fe0a77abd5ae2e17843
- 出典データセット
- uspto-grants-2003_08
- 特許番号
- US06602863B1
反応ノート
読み込み中…